COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

The Effect of Virtual Reality Glasses on Pain and Anxiety

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01659359
Recruitment Status : Completed
First Posted : August 7, 2012
Last Update Posted : August 8, 2012
Information provided by (Responsible Party):
Samira Ebrahimzadeh Zagami, Mashhad University of Medical Sciences

Brief Summary:
In recent studies using virtual reality has been proposed as a non pharmacological methods for pain relief but until this time , its effects has not been assessed on pain and anxiety during episiotomy repair. To determine the effectiveness of virtual reality Glasses on pain and anxiety in Primiparity women during episiotomy repair.

Condition or disease Intervention/treatment Phase
Pain and Anxiety Device: Virtual reality glasses and Lidocaine Drug: Lidocaine Phase 2 Phase 3

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 30 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Vice-presidency for Research
Study Start Date : January 2011
Actual Primary Completion Date : July 2012
Actual Study Completion Date : August 2012

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Anxiety Eye Wear

Arm Intervention/treatment
Experimental: virtual reality glasses and Lidocaine
virtual reality glasses and 5 ml Lidocaine 2%
Device: Virtual reality glasses and Lidocaine
The samples were randomly allocated to use Virtual reality glasses and 5 ml Lidocaine2% for decreasing pain and anxiety in episiotomy repair.

Experimental: Lidocaine
5 cc Lidocaine2%
Drug: Lidocaine
The samples were randomly allocated to use 5 ml Lidocaine2% for decreasing pain and anxiety in episiotomy repair.

Primary Outcome Measures :
  1. Virtual reality glasses decreased pain and anxiety during episiotomy [ Time Frame: up to 8 months ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years to 34 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Iranian
  • low risk pregnancy
  • Apgar ≥ 7

Exclusion Criteria:

  • vision or ear disorders
  • History of motion sickness or headaches
  • psychological disease or Addiction
  • Prescribe narcotic or sedation 4hour prior to delivery.

Layout table for additonal information
Responsible Party: Samira Ebrahimzadeh Zagami, Principle Investigator, Mashhad University of Medical Sciences Identifier: NCT01659359    
Other Study ID Numbers: virtual reality glasses
First Posted: August 7, 2012    Key Record Dates
Last Update Posted: August 8, 2012
Last Verified: August 2012
Additional relevant MeSH terms:
Layout table for MeSH terms
Anxiety Disorders
Mental Disorders
Anesthetics, Local
Central Nervous System Depressants
Physiological Effects of Drugs
Sensory System Agents
Peripheral Nervous System Agents
Anti-Arrhythmia Agents
Voltage-Gated Sodium Channel Blockers
Sodium Channel Blockers
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Central Nervous System Stimulants
Autonomic Agents
Dopamine Agents
Neurotransmitter Agents
Adrenergic Agents
Adrenergic Uptake Inhibitors
Neurotransmitter Uptake Inhibitors
Dopamine Uptake Inhibitors